Abstract
This paper argues that innovation diffusion is not a rational implementation process, but more accurately portrayed as a highly social process, involving sets of intermediate organizations that contribute to a product’s reputation. Empirically it builds on two case studies, one cultural and one science-based, to demonstrate there are industry differences in where innovations get validated: validating intermediaries are centralized in few global nodes in the case of theatre, and decentralized in each marketplace in the case of pharmaceutical vaccines. This pattern is counterintuitive, because it is different from what we would expect based on the spatial organization of their production activities. These findings have implications for policy: can we assume innovations will readily diffuse (and export) outside their region of origin?
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
